Showing posts with label hair loss treatment. Show all posts
Showing posts with label hair loss treatment. Show all posts

Thursday, October 13, 2016

5 Best Fixes for Hair Loss


The real deal on what works—and what doesn’t—when it comes to fighting hair loss. Whether you’ve just noticed a thinning hairline or you're constantly wearing a baseball hat to hide your bald spot, there's a good chance you’ve tried at least one product to keep your hair.

And while there are myriad products designed to fight hair loss, it can sometimes be hard to tell which methods to trust and which to toss. One hard truth: Hair loss is mostly out of your control. “Baldness comes down to your genes,” says Frederick Joyce, M.D., founder of Rejuvenate! Med Spa and a member of the International Society for Hair Restoration Surgery. “If you have the baldness gene, there are some natural remedies that may make your hair stronger and healthier to slow your hair loss slightly—but they won’t prevent you from going bald. Still, maintaining hair health by eating well and using the right products—combined with medical-grade treatments—can really work all together to help you have a fuller, thicker head of hair.”

There are some solutions that address the problem (using stem cells to regrow hair is promising) but many are still years away from becoming available as a hair loss treatment. So here's the lowdown on which baldness solutions available now are truly effective—and which hair-loss fighters are merely snake oil.

1. Nutrition
2. Nioxin Shampoo
3. Laser Light Therapy
4. Propecia
5. Minoxidil

Wednesday, December 30, 2015

The FDA Just Approved a New Treatment That Reduces Hair Loss During Chemotherapy

It's already stressful to come to terms with a breast cancer diagnosis, but losing your hair during chemotherapy treatment can cause so much distress for any patient. Fortunately, there's now a device that women can use to regain some form of normalcy in their lives during treatment.

Last Tuesday, for the first time, the FDA approved a scalp cooling system, Dignitana DigniCap Cooling System, which reduces hair loss in female breast cancer patients undergoing chemotherapy. The cap, made by Swedish manufacturer, Dignitana Inc, is intended to reduce the frequency and severity of alopecia during chemotherapy. Operated by a computer-controlled system, the cap circulates cooled liquid to a cooling cap during chemo. A second cap is placed over the cooling cap, which holds it in place and serves as insulation to prevent the loss of coolness.

The FDA described the process in their release, saying, "The cooling action is intended to constrict blood vessels in the scalp, which, in theory, reduces the amount of chemotherapy that reaches cells in the hair follicles (hair roots). The cold also decreases the activity of the hair follicles, which slows down cell division and makes them less affected by chemotherapy. The combined actions are thought to reduce the effect chemotherapy has on the cells, which may reduce hair loss."

According to Dignitana, 7 out of 10 patients with early stage breast cancer kept at least 50 percent of their hair. For one clinical trial participant, Deanna King, none of her hair fell out.

"I had 100 percent success rate," King says. "I was very fortunate. I was on the right chemo regimen and my hair didn't fall out at all. Had my scalp not frozen, all of my hair would have fallen out."

For breast cancer patients, this was a way to regain control. King told Cosmopolitan.com, "I started doing research and what I wanted to do is try to have some control over my treatment plan. You know I wanted to be really proactive and advocate for myself."

Dr. Hope Rugo, principal investigator for the study and director of Breast Oncology and Clinical Trials Education at the UCSF Helen Diller Family Comprehensive Cancer Center, explained that this cap can be used for different cancers as well. "It's not as if, for example, someone with an ovarian cancer can't use it. They could; it's just that the FDA gives specific approval to what you studied in your trial. But you can certainly use it and it's being used worldwide for other cancers. We don't recommend it for liquid tumors like leukemia because [tumor cells are] everywhere at once and it would be very hard for it to work."

There are currently different non-FDA approved cooling caps being used on the market, such as the Penguin Cooling Cap, which you have to freeze and change the cap every 30 minutes. The Penguin Cap, however, is manufactured with FDA-approved materials.

King was enthusiastic about the DigniCap specially since there was less room for human error, which would make the process ineffective. "It's a device where people who use cold caps have to have another person changing the caps all the time and making sure they're the right temperature, so there's a lot more room for error. It's much harder to do. Whereas this is an actual machine and all you have to do is just sit there."

The FDA noted that side effects included cold-induced headaches, neck and shoulder discomfort, and chills and pain associated with wearing the cap for a long period of time.

CBS News spoke to Dignitana's chief operating officer, Bill Cronin, who said that depending how many rounds of chemo a woman would goes through, the total cost of using the cap could be between $1,500 to $3,000.

Dignitiana is currently finalizing their agreements with major centers and community oncology groups across the country so DigniCaps will be available to patients as soon as possible.

Thursday, January 15, 2015

Substance from honeybee hives may help with hair loss

Could honeybees help with human hair loss?acs.org
A substance from honeybee hives might contain clues for developing a potential new therapy for human baldness: a material called propolis that encouraged hair growth in mice.
Propolis is a resinlike material that honeybees use to seal small gaps in their hives. It works as a physical barrier – but also contains active compounds that fight fungal and bacterial invasions. People from ancient times had noticed propolis’ special properties and used it to treat tumors, inflammation and wounds. Research has also shown that the substance promotes the growth of certain cells involved in hair growth, though no one had yet tested whether that in turn would result in new locks.
When researcher Ken Kobayashi and colleagues tested propolis on mice that had been shaved or waxed, the mice that received the treatment regrew their fur faster than those that didn’t. The scientists also noticed that after the topical application, the number of special cells involved in the process of growing hair increased. Although they tried the material on mice that could grow fur, rather than balding mice, the researchers note that hair loss conditions often result from abnormal inflammation. Propolis contains anti-inflammatory compounds, so they expect it could help treat balding conditions.
They add that further testing is needed to see whether the beehive material affects human hair follicles. The study appears in the American Chemical Society’s Journal of Agricultural and Food Chemistry .




Read more here: http://www.newsobserver.com/2015/01/11/4456979/substance-from-honeybee-hives.html#storylink=cpy

Thursday, July 3, 2014

New Clinical Trial By US Oncology Research Tests Chemotherapy-Induced Hair Loss Therapy

US Oncology Research, one of the leading community-based cancer research networks in America based in The Woodlands, Texas, and Baylor College of Medicine, have launched a clinical trial titled “Scalp Cooling Alopecia Prevention Trial” (SCALP), which will examine an existing scalp cooling system aiming to critically reduce or completely stop chemotherapy-related hair loss, which occurs in about 65% of cancer patients undergoing chemotherapy and is one of the most disturbing and stressful factors in cancer patient care.

So far, a total of 15 patients have registered and approximately 50 more are being recruited at three US Oncology Research sites: Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, led by Cynthia Osborne, M.D.; Texas Oncology-Memorial City, Houston, Texas, led by Frankie Ann Holmes, M.D., and Hematology-Oncology Associates of Northern New Jersey, P.A., Morristown, N.J., led by Steven Papish, M.D., F.A.C.P.

Newly diagnosed female patients (18 years or older) with stage 1-2 breast cancer planning to undergo at least 4 cycles of full-dose anthracycline or taxane neoadjuvant or adjuvant chemotherapy are encouraged to contact one of these three participating centers for more information.

Here is the link for the trial and contact information for recruiting:
http://clinicaltrials.gov/show/NCT01986140